Embed this press release by copying the code below:
NASDAQ:OBLN Shareholder Notice: Investigation over Potential Wrongdoing at Obalon Therapeutics Inc
NASDAQ:OBLN Shareholder Notice: Investigation over Potential Wrongdoing at Obalon Therapeutics Inc